Sankaran Mirunalini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sankaran Mirunalini has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Manobharathi Vengaimaran
6 shared publicationsKalaiyarasi Dhamodharan
5 shared publicationsGanesan Dhamodharan
Department of Biochemistry & Biotechnology, Annamalai University, Annamalai Nagar, 608 002 Tamil Nadu, India
2 shared publicationsKrishnamoorthy Deepalakshmi
2 shared publicationsM. Krishnaveni
Annamalai University, Annamalainagar – 608 002, Tamil Nadu
2 shared publicationsStainsloss Isabella
Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu 608 002 India
2 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (7) , 1843-1852
Synthesis and Characterisation of Marine Docosahexaenoic Acid-Encapsulated Chitosan Nanoparticles (DHA@CSNP) and Evaluation of their Antioxidant and Cytotoxic Activities
Docosahexaenoic acid (DHA) is an essential ω-3 polyunsaturated fatty acid with demonstrated health benefits, including neuroprotection, anti-inflammatory effects and anticancer activity. However, its poor water solubility, susceptibility to oxidative degradation and low bioavailability limit therapeutic applications. This study aimed to improve the stability and therapeutic efficacy of DHA through nano-encapsulation within chitosan nanoparticles (DHA@CSNPs), synthesised through ionic gelation method using sodium tripolyphosphate as a crosslinking agent. The synthesised nanoparticles were characterised by SEM, FE-SEM with EDX, FTIR, XRD, DLS and zeta potential analysis. DHA@CSNPs exhibited nanoscale morphology (average particle size 76.53 ± 3.41 nm), semi-crystalline structure and a positive surface charge of 21.63 mV, confirming colloidal stability and successful encapsulation. Encapsulation efficiency was 83.38 ± 1.48% and in vitro release studies demonstrated pH-dependent sustained release, with higher release at acidic pH, mimicking tumor microenvironments. Antioxidant potential was evaluated using ABTS, DPPH, hydroxyl, superoxide, nitric oxide and reducing power assays, showing enhanced radical-scavenging activity and lower IC50 values for DHA@CSNPs than for free DHA. Cytotoxicity against MDA-MB-231 triple-negative breast cancer cells revealed a dose-dependent decrease in cell viability with an IC50 of 59.30 µg/mL and pronounced morphological changes indicative of apoptosis. These results highlight that chitosan-based nanocarriers effectively improve DHA’s stability, bioavailability and therapeutic potential.
- 3 July 2026
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 38 (7) , 1843-1852
Open AccessSynthesis and Characterisation of Marine Docosahexaenoic Acid-Encapsulated Chitosan Nanoparticles (DHA@CSNP) and Evaluation of their Antioxidant and Cytotoxic Activities
Docosahexaenoic acid (DHA) is an essential ω-3 polyunsaturated fatty acid with demonstrated health benefits, including neuroprotection, anti-inflammatory effects and anticancer activity. However, its poor water solubility, susceptibility to oxidative degradation and low bioavailability limit therapeutic applications. This study aimed to improve the stability and therapeutic efficacy of DHA through nano-encapsulation within chitosan nanoparticles (DHA@CSNPs), synthesised through ionic gelation method using sodium tripolyphosphate as a crosslinking agent. The synthesised nanoparticles were characterised by SEM, FE-SEM with EDX, FTIR, XRD, DLS and zeta potential analysis. DHA@CSNPs exhibited nanoscale morphology (average particle size 76.53 ± 3.41 nm), semi-crystalline structure and a positive surface charge of 21.63 mV, confirming colloidal stability and successful encapsulation. Encapsulation efficiency was 83.38 ± 1.48% and in vitro release studies demonstrated pH-dependent sustained release, with higher release at acidic pH, mimicking tumor microenvironments. Antioxidant potential was evaluated using ABTS, DPPH, hydroxyl, superoxide, nitric oxide and reducing power assays, showing enhanced radical-scavenging activity and lower IC50 values for DHA@CSNPs than for free DHA. Cytotoxicity against MDA-MB-231 triple-negative breast cancer cells revealed a dose-dependent decrease in cell viability with an IC50 of 59.30 µg/mL and pronounced morphological changes indicative of apoptosis. These results highlight that chitosan-based nanocarriers effectively improve DHA’s stability, bioavailability and therapeutic potential.
- Open Access
- 12 April 2023
- Published by IntechOpen
Pharmacological Properties and Health Benefits of Capsicum Species: A Comprehensive Review
Since the start of history, natural medicine has been of great interest and attention to humankind. A heap of empirical research indicates that spices have undoubtedly made our lives more interesting and may also make them longer. Capsicum is a highly regarded indispensable spice all over the globe for its umpteen culinary and medicinal facets. It has been used for more than 7000 years in Mexico and is believed to have originated in tropical Central America. Mainly, this botanical contains a good source of vitamin C, vitamin A, vitamin E, vitamin B5, potassium, magnesium, iron, calcium, phosphorus, and carotenoids. Interestingly, capsicum phenolic compounds are helpful in preventing and treating many ailments. So, it intends as a beneficial milestone in the pharmaceutical industry and a boon to humanity. This chapter highlights the tremendous pharmacological uses and health benefits of capsicum species and its active compounds in multifarious aspects.
- 12 April 2023
- Published by IntechOpen
Open AccessPharmacological Properties and Health Benefits of Capsicum Species: A Comprehensive Review
Since the start of history, natural medicine has been of great interest and attention to humankind. A heap of empirical research indicates that spices have undoubtedly made our lives more interesting and may also make them longer. Capsicum is a highly regarded indispensable spice all over the globe for its umpteen culinary and medicinal facets. It has been used for more than 7000 years in Mexico and is believed to have originated in tropical Central America. Mainly, this botanical contains a good source of vitamin C, vitamin A, vitamin E, vitamin B5, potassium, magnesium, iron, calcium, phosphorus, and carotenoids. Interestingly, capsicum phenolic compounds are helpful in preventing and treating many ailments. So, it intends as a beneficial milestone in the pharmaceutical industry and a boon to humanity. This chapter highlights the tremendous pharmacological uses and health benefits of capsicum species and its active compounds in multifarious aspects.
- 8 March 2023
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 7 (1) , 70-82
Therapeutic Impact of Nano Diosgenin on Metabolic Reprogramming in an Animal Model of Mammary Oncogenesis Modulating Carbohydrate Metabolizing Enzymes
Objectives: The primary target of this study is to explore a novel therapeutic pathway of nano Diosgenin (DG) by pinpointing the metabolic enzymes that underlies its anti-breast cancer impacts. Methods: A single dosage of 7.12 Dimethyl Benz(a)anthracene (DMBA) (25 mg/kg b.wt) was injected to induce breast cancer. Oral administration of DG (10 mg/kg b.wt) and DG encapsulated chitosan nanoparticle (DG@CS-NP) (5 mg/kg b.wt) was used to medicate DMBA induced tumor bearing rats just after the emergence of a tumor. After the experimental period, biochemical analyses were carried out. Results: Mammary carcinoma bearing rats showed a significant rise in the levels of glycolytic enzymes (hexokinase, phosphoglucoisomerase, and aldolase) and the pentose phosphate pathway enzyme (glucose-6-phosphate dehydrogenase). It also elicits a drop in gluconeogenic enzymes (glucose-6-phosphatase and fructose 1, 6- diphosphatase) and mitochondrial enzymes (succinate dehydrogenase and malate dehydrogenase). Contrarily, nano DG dramatically reverted the rates of glycolytic enzymes, pentose phosphate pathway enzymes, gluconeogenic enzymes, and mitochondrial enzymes in the mammary, liver and kidney tissues to near normal tiers on compared to plain DG treated rats. Thereby, confirming its chemotherapeutic prospects on metabolic rewiring. Conclusion: Thus, our observations suggested that nano DG is a potent therapeutic agent that might have a significant influence on metabolic complications of breast cancer than free DG.
- 8 March 2023
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 7 (1) , 70-82
Therapeutic Impact of Nano Diosgenin on Metabolic Reprogramming in an Animal Model of Mammary Oncogenesis Modulating Carbohydrate Metabolizing Enzymes
Objectives: The primary target of this study is to explore a novel therapeutic pathway of nano Diosgenin (DG) by pinpointing the metabolic enzymes that underlies its anti-breast cancer impacts. Methods: A single dosage of 7.12 Dimethyl Benz(a)anthracene (DMBA) (25 mg/kg b.wt) was injected to induce breast cancer. Oral administration of DG (10 mg/kg b.wt) and DG encapsulated chitosan nanoparticle (DG@CS-NP) (5 mg/kg b.wt) was used to medicate DMBA induced tumor bearing rats just after the emergence of a tumor. After the experimental period, biochemical analyses were carried out. Results: Mammary carcinoma bearing rats showed a significant rise in the levels of glycolytic enzymes (hexokinase, phosphoglucoisomerase, and aldolase) and the pentose phosphate pathway enzyme (glucose-6-phosphate dehydrogenase). It also elicits a drop in gluconeogenic enzymes (glucose-6-phosphatase and fructose 1, 6- diphosphatase) and mitochondrial enzymes (succinate dehydrogenase and malate dehydrogenase). Contrarily, nano DG dramatically reverted the rates of glycolytic enzymes, pentose phosphate pathway enzymes, gluconeogenic enzymes, and mitochondrial enzymes in the mammary, liver and kidney tissues to near normal tiers on compared to plain DG treated rats. Thereby, confirming its chemotherapeutic prospects on metabolic rewiring. Conclusion: Thus, our observations suggested that nano DG is a potent therapeutic agent that might have a significant influence on metabolic complications of breast cancer than free DG.
- 6 June 2022
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 6 (2) , 142-149
Structure-Based Molecular Docking Studies toward Exploring Phytoestrogen against Breast Cancer
Objectives: Breast cancer (BCa) remains the world’s second biggest cause of cancer death. This occurs as a result of unregulated cell development and can be metastasized to other parts of the human. Estrogen receptor alpha is the renowned target that has piqued the interest of researchers to target BCa. FlexX molecular docking technique was used to predict the aspects of interaction, affinities energy, and orientation of natural compounds in the protein site. Phytoconstituents have a vital role in anticancer activities due to their important scaffolds, which may offer more effective and reduced costs and side effects than synthetic drugs. The present study aims to identify new anticancer agents from natural and dietary compounds with lesser adverse effects. Methods: To accomplish this, we implemented with the help of molecular docking approaches using FlexX for predicting the features of bioactive phytocompounds from natural products and evaluating targeted binding affinity energy. Results: Our results confirm that among various natural compounds, daidzein has the best docking score in the ten compounds compared with the standard drug cytarabine. Conclusion: Our study suggests that daidzein is a potent ligand for ERα BCa among all and can be further investigated through in vitro and in vivo studies.
- 6 June 2022
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 6 (2) , 142-149
Structure-Based Molecular Docking Studies toward Exploring Phytoestrogen against Breast Cancer
Objectives: Breast cancer (BCa) remains the world’s second biggest cause of cancer death. This occurs as a result of unregulated cell development and can be metastasized to other parts of the human. Estrogen receptor alpha is the renowned target that has piqued the interest of researchers to target BCa. FlexX molecular docking technique was used to predict the aspects of interaction, affinities energy, and orientation of natural compounds in the protein site. Phytoconstituents have a vital role in anticancer activities due to their important scaffolds, which may offer more effective and reduced costs and side effects than synthetic drugs. The present study aims to identify new anticancer agents from natural and dietary compounds with lesser adverse effects. Methods: To accomplish this, we implemented with the help of molecular docking approaches using FlexX for predicting the features of bioactive phytocompounds from natural products and evaluating targeted binding affinity energy. Results: Our results confirm that among various natural compounds, daidzein has the best docking score in the ten compounds compared with the standard drug cytarabine. Conclusion: Our study suggests that daidzein is a potent ligand for ERα BCa among all and can be further investigated through in vitro and in vivo studies.
- 1 June 2022
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 18 (3) , 196-212
In silico Approach and Molecular Docking Studies of Potent Bioactive Compounds of Carica papaya as Anti-breast Cancer Agents
Background: Breast cancer is one of the greatest global dilemmas, and the current treatment option is to target hormone receptors with partial agonists/antagonists. Estrogen and aromatase enzymes play important roles in breast cancer. Excessive estrogen activity or inadequate estrogen production leads to various hormonal issues, including breast cancer. Potent breast cancer drugs are Tamoxifen, Paclitaxel, Cyclophosphamide, Trastuzumab, etc., and aromatase inhibitors, include Anastrozole, Letrozole, and Exemestane, etc. In general, breast cancer drugs cause numerous adverse effects in humans. Objectives: This study has attempted to identify alternative drug candidates from Carica papaya for treating breast cancer with fewer side effects. Methods: To achieve this, we have utilized computational methods to predict the characteristics of bioactive compounds from Carica papaya and determine the target binding affinities using the Schrödinger suite (Maestro 9.5). The target protein and ligands were obtained from the well-known database. Carica papaya has 35 identified bioactive compounds that were drawn using ChemDraw software and performed Ligand preparation wizard. Absorption, Distribution, Metabolism, and Excretion (ADME) analysis is performed with QikProp. Results: From the docking studies, the phytocompounds such as Chlorogenic acid, Myricetin, Quercetin, Isorhamnetin, and Catechin showed the highest Glide scores (G Score). Among the five bioactive phytocompounds, Chlorogenic acid has a higher G Score with good binding energy than Tamoxifen, Anastrozole, and Letrozole standards. The pharmacokinetic properties and drug-likeness of phytocompounds were determined using ADME profiling. Conclusion: Carica papaya phytocompounds serve as an antiestrogen or aromatase inhibitor that regulates estrogen levels to reduce the risk of breast cancer in postmenopausal women. As a result, we recommend that these top five bioactive phytocompounds be investigated further in in vitro and in vivo studies.
- 1 June 2022
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 18 (3) , 196-212
In silico Approach and Molecular Docking Studies of Potent Bioactive Compounds of Carica papaya as Anti-breast Cancer Agents
Background: Breast cancer is one of the greatest global dilemmas, and the current treatment option is to target hormone receptors with partial agonists/antagonists. Estrogen and aromatase enzymes play important roles in breast cancer. Excessive estrogen activity or inadequate estrogen production leads to various hormonal issues, including breast cancer. Potent breast cancer drugs are Tamoxifen, Paclitaxel, Cyclophosphamide, Trastuzumab, etc., and aromatase inhibitors, include Anastrozole, Letrozole, and Exemestane, etc. In general, breast cancer drugs cause numerous adverse effects in humans. Objectives: This study has attempted to identify alternative drug candidates from Carica papaya for treating breast cancer with fewer side effects. Methods: To achieve this, we have utilized computational methods to predict the characteristics of bioactive compounds from Carica papaya and determine the target binding affinities using the Schrödinger suite (Maestro 9.5). The target protein and ligands were obtained from the well-known database. Carica papaya has 35 identified bioactive compounds that were drawn using ChemDraw software and performed Ligand preparation wizard. Absorption, Distribution, Metabolism, and Excretion (ADME) analysis is performed with QikProp. Results: From the docking studies, the phytocompounds such as Chlorogenic acid, Myricetin, Quercetin, Isorhamnetin, and Catechin showed the highest Glide scores (G Score). Among the five bioactive phytocompounds, Chlorogenic acid has a higher G Score with good binding energy than Tamoxifen, Anastrozole, and Letrozole standards. The pharmacokinetic properties and drug-likeness of phytocompounds were determined using ADME profiling. Conclusion: Carica papaya phytocompounds serve as an antiestrogen or aromatase inhibitor that regulates estrogen levels to reduce the risk of breast cancer in postmenopausal women. As a result, we recommend that these top five bioactive phytocompounds be investigated further in in vitro and in vivo studies.
- 14 February 2022
- Published by Sciencedomain International
- p. 102-110
Pharmacological and Therapeutic Aspects of Diosgenin: A Prospects for Its Pharmaceutical Development
Diosgenin, a steroidal saponin spotted in legumes and yams, has been used for the treatment of a multitude of disorders like leukemia, inflammation, hypercholesterolemia and cancer. Besides being a lactation aid, it has been proven as a gastro- and hepato-protective, anti-oxidant, anti-diabetic and Vaso-dilatory compound. It is also a precursor for the production of several steroidal hormones. Hence, with this background, this chapter focuses on diosgenin’s pharmacological assets which evidently supports its clinical therapeutic implementation.
- 14 February 2022
- Published by Sciencedomain International
- p. 102-110
Pharmacological and Therapeutic Aspects of Diosgenin: A Prospects for Its Pharmaceutical Development
Diosgenin, a steroidal saponin spotted in legumes and yams, has been used for the treatment of a multitude of disorders like leukemia, inflammation, hypercholesterolemia and cancer. Besides being a lactation aid, it has been proven as a gastro- and hepato-protective, anti-oxidant, anti-diabetic and Vaso-dilatory compound. It is also a precursor for the production of several steroidal hormones. Hence, with this background, this chapter focuses on diosgenin’s pharmacological assets which evidently supports its clinical therapeutic implementation.
- 1 December 2021
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 5 (4) , 350-357
Chemomodulatory Effect of Capsaicin Encapsulated Chitosan Nanoparticles on Lipids, Lipoproteins and Glycoprotein Components in DMBA Induced Mammary Carcinogenesis in Rats
Objectives: Breast cancer is a dreadful public health issue that kills plenty of women all around the world. The peril of breast cancer is strongly linked to lipids, lipoproteins, and glycoproteins. Capsaicin (CAP), a natural alkaloid isolated from chilies, has been reported to possess excellent anti-cancer activity. Unfortunately, the clinical application of this compound is strictly limited due to its low solubility and poor bioavailability. Nanoparticle-based drug delivery systems have set the path for a revolution in cancer therapy by improving its therapeutic value. The aim of the present study was to investigate the effect of CAP encapsulated chitosan nanoparticles (CAP@CS-NP) on lipids, lipoproteins and glycoproteins abnormalities in 7,12-dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis. Methods: A mammary tumor was induced by a single dose of DMBA 25mg/kg b.wt injected subcutaneously near the mammary gland. The levels of lipid profile, lipoproteins and glycoprotein components were analyzed in the plasma, liver and mammary tissues. Results: We observed higher levels of total cholesterol (TC), triglycerides (TG), phospholipids (PL), free fatty acids (FFA), hexose, hexosamine and sialic acid in DMBA induced tumor-bearing rats. Moreover, low-density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) levels were raised and high-density lipoprotein cholesterol (HDL-C) levels were dropped in tumor-bearing rats. The result shows that, CAP@CS-NP 4mg/kg b.wt administration significantly recouped abnormal levels to near-normal levels. It was additionally verified by histological staining in mammary tissues. Conclusion: Our findings suggest that nanoencapsulation of CAP@CS-NP successfully regulates lipid profile, lipoproteins, and glycoproteins levels.
- 1 December 2021
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 5 (4) , 350-357
Chemomodulatory Effect of Capsaicin Encapsulated Chitosan Nanoparticles on Lipids, Lipoproteins and Glycoprotein Components in DMBA Induced Mammary Carcinogenesis in Rats
Objectives: Breast cancer is a dreadful public health issue that kills plenty of women all around the world. The peril of breast cancer is strongly linked to lipids, lipoproteins, and glycoproteins. Capsaicin (CAP), a natural alkaloid isolated from chilies, has been reported to possess excellent anti-cancer activity. Unfortunately, the clinical application of this compound is strictly limited due to its low solubility and poor bioavailability. Nanoparticle-based drug delivery systems have set the path for a revolution in cancer therapy by improving its therapeutic value. The aim of the present study was to investigate the effect of CAP encapsulated chitosan nanoparticles (CAP@CS-NP) on lipids, lipoproteins and glycoproteins abnormalities in 7,12-dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis. Methods: A mammary tumor was induced by a single dose of DMBA 25mg/kg b.wt injected subcutaneously near the mammary gland. The levels of lipid profile, lipoproteins and glycoprotein components were analyzed in the plasma, liver and mammary tissues. Results: We observed higher levels of total cholesterol (TC), triglycerides (TG), phospholipids (PL), free fatty acids (FFA), hexose, hexosamine and sialic acid in DMBA induced tumor-bearing rats. Moreover, low-density lipoprotein cholesterol (LDL-C) and very low-density lipoprotein cholesterol (VLDL-C) levels were raised and high-density lipoprotein cholesterol (HDL-C) levels were dropped in tumor-bearing rats. The result shows that, CAP@CS-NP 4mg/kg b.wt administration significantly recouped abnormal levels to near-normal levels. It was additionally verified by histological staining in mammary tissues. Conclusion: Our findings suggest that nanoencapsulation of CAP@CS-NP successfully regulates lipid profile, lipoproteins, and glycoproteins levels.
- 25 October 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (47A) , 141-157
Diosgenin Nanoparticles Competes Plain Diosgenin on Reviving Biochemical and Histopathological Alterations in DMBA Induced Rat Mammary Carcinoma via Modulating the AhR-Nrf-2 Signaling Cascades
Background: Diosgenin, a steroidal saponin spotted as a primary ingredient in many traditional Chinese medicines, has sparked the attention of researchers owing to its multi-targeted cytotoxicity towards a multitude of cancers. Regrettably, its true potential was bounded by its impoverished physicochemical properties. In order to fully exploit its ability, we plan to fabricate diosgenin into nanoparticle by encapsulating with biodegradable polymer chitosan. Aim: The current research intends to uncover the therapeutic potency of diosgenin encapsulated chitosan nanoparticles (DG@CS-NP) on 7,12dimethylbenz(a)anthracene (DMBA) induced rat mammary carcinoma by optimizing biochemical and histopathological modifications via attenuating Aryl hydrocarbon receptor (AhR) - nuclear factor erythroid-derived 2-related factors (Nrf-2) signaling. Methodology: Breast cancer was induced with a single dose of DMBA (25 mg/kg b.wt). Orally supplied DG 10mg/kg b.wt. and DG@CS-NP 5 mg/kg b.wt to DMBA-induced tumor-bearing rats shortly after tumor onset. After the experimental period, biochemical and histopathological studies were performed using mammary tissue sections. Furthermore, architectural immunohistochemistry was used to reveal the expression of AhR and Nrf-2 in experimental rats. Additionally, diosgenin interactions with these proteins were also evidently confirmed by molecular docking analysis. Result: We noticed that there is an elevated level of lipid peroxidative marker, phase-I detoxification enzymes, total cholesterol (TC), phospholipids (PL), triglycerides (TG), and free fatty acids (FFA) with boosted AhR expressions as well as diminished levels of enzymatic and non-enzymatic antioxidants and Phase – II detoxification enzymes with downtrodden Nrf-2 expressions in the mammary tissues of DMBA-induced rats. On the other contrary, oral dosing of DG@CS-NP 5 mg/kg b.wt, dramatically reverted them to near-normal tiers. Interestingly, molecular docking analyses also corroborate these insights by highlighting diosgenin's significant interactions with AhR and Nrf-2 targets. Conclusion: As an outcome of our observations, we conclude that nano-encapsulation of diosgenin is a potent targeted therapeutic candidate posing a massive impact on breast cancer than plain diosgenin.
- 25 October 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (47A) , 141-157
Diosgenin Nanoparticles Competes Plain Diosgenin on Reviving Biochemical and Histopathological Alterations in DMBA Induced Rat Mammary Carcinoma via Modulating the AhR-Nrf-2 Signaling Cascades
Background: Diosgenin, a steroidal saponin spotted as a primary ingredient in many traditional Chinese medicines, has sparked the attention of researchers owing to its multi-targeted cytotoxicity towards a multitude of cancers. Regrettably, its true potential was bounded by its impoverished physicochemical properties. In order to fully exploit its ability, we plan to fabricate diosgenin into nanoparticle by encapsulating with biodegradable polymer chitosan. Aim: The current research intends to uncover the therapeutic potency of diosgenin encapsulated chitosan nanoparticles (DG@CS-NP) on 7,12dimethylbenz(a)anthracene (DMBA) induced rat mammary carcinoma by optimizing biochemical and histopathological modifications via attenuating Aryl hydrocarbon receptor (AhR) - nuclear factor erythroid-derived 2-related factors (Nrf-2) signaling. Methodology: Breast cancer was induced with a single dose of DMBA (25 mg/kg b.wt). Orally supplied DG 10mg/kg b.wt. and DG@CS-NP 5 mg/kg b.wt to DMBA-induced tumor-bearing rats shortly after tumor onset. After the experimental period, biochemical and histopathological studies were performed using mammary tissue sections. Furthermore, architectural immunohistochemistry was used to reveal the expression of AhR and Nrf-2 in experimental rats. Additionally, diosgenin interactions with these proteins were also evidently confirmed by molecular docking analysis. Result: We noticed that there is an elevated level of lipid peroxidative marker, phase-I detoxification enzymes, total cholesterol (TC), phospholipids (PL), triglycerides (TG), and free fatty acids (FFA) with boosted AhR expressions as well as diminished levels of enzymatic and non-enzymatic antioxidants and Phase – II detoxification enzymes with downtrodden Nrf-2 expressions in the mammary tissues of DMBA-induced rats. On the other contrary, oral dosing of DG@CS-NP 5 mg/kg b.wt, dramatically reverted them to near-normal tiers. Interestingly, molecular docking analyses also corroborate these insights by highlighting diosgenin's significant interactions with AhR and Nrf-2 targets. Conclusion: As an outcome of our observations, we conclude that nano-encapsulation of diosgenin is a potent targeted therapeutic candidate posing a massive impact on breast cancer than plain diosgenin.
- 16 August 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (41A) , 126-144
Capsaicin Encapsulated Chitosan Nanoparticles Augments Anticarcinogenic and Antiproliferative Competency Against 7,12 Dimethylbenz(a)anthracene Induced Experimental Rat Mammary Carcinogenesis
Background: Capsaicin is a powerful phytochemical spotted in chilies, starkly tied up with a bunch of health benefits but its clinical applications in cancer therapy are limited due to its poor solubility, and low bioavailability. Nanotechnology offers a strategy to discover new formulations for hydrophobic agent. Aim: The main intent of the current research was to investigate the effect of Capsaicin encapsulated chitosan nanoparticles (CAP@CS-NP) on 7,12-Dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis in rats. Methodology: Mammary tumor was induced in female rats by injecting DMBA (25mg/kg b.wt) at the first week of the experiment. After 7 weeks, CAP@CS-NP (4mg/kg b.wt) was administered orally to DMBA induced tumor bearing rats for 21 days (thrice per week). The experiment was terminated at the end of the 14th week and their plasma and tissue sections were analyzed. Results: We found that significantly elevated levels of lipid peroxidation and diminished levels of antioxidant status in plasma, liver and mammary tissues. Increased levels of detoxification phase I enzymes and dropped levels of phase II enzymes in liver and mammary tissues in DMBA induced tumor bearing rats. As a result, oral administration of CAP@CS-NP suppressed the tumor growth, significantly raised body weight and restored abnormal enzymatic levels to near normal ranges. Additionally, histopathological and immunohistochemical analysis were also confirmed that CAP@CS-NP protects DMBA mediated cellular disruption and also inhibits abnormal cell proliferation. Conclusion: These findings suggest that nano encapsulation of CAP@CS-NP could be useful in targeted drug delivery and act as a promising chemotherapeutic agent to treat mammary carcinogenesis.
- 16 August 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (41A) , 126-144
Capsaicin Encapsulated Chitosan Nanoparticles Augments Anticarcinogenic and Antiproliferative Competency Against 7,12 Dimethylbenz(a)anthracene Induced Experimental Rat Mammary Carcinogenesis
Background: Capsaicin is a powerful phytochemical spotted in chilies, starkly tied up with a bunch of health benefits but its clinical applications in cancer therapy are limited due to its poor solubility, and low bioavailability. Nanotechnology offers a strategy to discover new formulations for hydrophobic agent. Aim: The main intent of the current research was to investigate the effect of Capsaicin encapsulated chitosan nanoparticles (CAP@CS-NP) on 7,12-Dimethylbenz(a)anthracene (DMBA) induced mammary carcinogenesis in rats. Methodology: Mammary tumor was induced in female rats by injecting DMBA (25mg/kg b.wt) at the first week of the experiment. After 7 weeks, CAP@CS-NP (4mg/kg b.wt) was administered orally to DMBA induced tumor bearing rats for 21 days (thrice per week). The experiment was terminated at the end of the 14th week and their plasma and tissue sections were analyzed. Results: We found that significantly elevated levels of lipid peroxidation and diminished levels of antioxidant status in plasma, liver and mammary tissues. Increased levels of detoxification phase I enzymes and dropped levels of phase II enzymes in liver and mammary tissues in DMBA induced tumor bearing rats. As a result, oral administration of CAP@CS-NP suppressed the tumor growth, significantly raised body weight and restored abnormal enzymatic levels to near normal ranges. Additionally, histopathological and immunohistochemical analysis were also confirmed that CAP@CS-NP protects DMBA mediated cellular disruption and also inhibits abnormal cell proliferation. Conclusion: These findings suggest that nano encapsulation of CAP@CS-NP could be useful in targeted drug delivery and act as a promising chemotherapeutic agent to treat mammary carcinogenesis.